Dr. Reddy’s introduces generic CubicinCubicin for injection had a market value of roughly $640.8 million for the most recent 12 months ended in March 2019, according to IQVIA data. AAM sends letters to House on HR 987The Association for Accessible Medicines has sent two letters to Capital Hill in advance of House consideration of H.R. 987. CVS Pharmacy launches ‘Tested to Be Trusted’ program, intros 300 health-and-wellness items More than 1,400 products across 11 categories have been tested to verify labeled ingredients through the “Tested to Be Trusted” program. Mylan launches generic Tarceva Erlotinib hydrochloride tablets have a market value of roughly $212 million. Amerigen's generic Cuprimine gets FDA OK The Food and Drug Administration approved Cuprimine's penicillamine capsules. higi offers free health screenings for World Hypertension Day To emphasize the importance of World Hypertension Day on May 17, higi's "This Year I Can" campaign will offer free health screenings. Walgreens Boots Alliance's new initiative supports people living with cancer Walgreens Boots Alliance and three cancer organizations are collaborating to support people living with cancer. March of Dimes' annual Gourmet Gala raises $1.3M A total of $1.3 million was raised during the March of Dimes Gourmet Gala to support the health of mothers and babies. Teva launches generic Delzicol Delzicol delayed-release capsules have a market value of roughly $130 million, according to February 2019 IQVIA data. Teva launches generic Tarceva Tarceva tablets have a market value of $202 million, according to IQVIA data as of February 2019. First Previous 472 473 474 475 476 Next Last
